Herceptin

Latest stories

2d
Business Wire
Puma Biotechnology Submits Marketing Authorization Application for PB272 (Neratinib) as Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer in Europeextended adjuvant treatment of HER2-positive early stage breast cancer that has
Puma Biotechnology Submits Marketing Authorization Application for PB272 (Neratinib) as Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer in Europe
Business Wire / Posted 2 days ago
extended adjuvant treatment of HER2-positive early stage breast cancer that has previously been treated with trastuzumab (Herceptin®)-based adjuvant therapy. The submission is based upon the ExteNET Phase III study, which reached its primary... Read more
2d
Hunts Post
Goldielocks sheds hair for cancer suffering mumago - they have all got me through this.” Jamie Farrington's brother shaving t
Goldielocks sheds hair for cancer suffering mum
Hunts Post / Posted 2 days ago
ago - they have all got me through this.” Jamie Farrington's brother shaving the 28-year-old's head Ms Wright will start a nine-month Herceptin, an expensive cancer treatment drug programme this week and hopes to get the all clear later this... Read more
7d
Daily Record
Scottish mum in fundraising bid to prolong her lifeI wouldn’t have to worry about the cancer returning. "I was grateful to have d
Scottish mum in fundraising bid to prolong her life
Daily Record / Posted 7 days ago
I wouldn’t have to worry about the cancer returning. "I was grateful to have dodged a bullet.” Lesley was prescribed Herceptin, a drug used to help control the growth of cancerous cells, and was told she could look to the future with husband... Read more
8d
The Financial Express
How to choose health insurance: All you want to knowthat compounds problems is the rising costs of healthcare and the rising incide
How to choose health insurance: All you want to know
The Financial Express / Posted 8 days ago
that compounds problems is the rising costs of healthcare and the rising incidence rates of such illnesses. For example, Herceptin, an effective drug for breast cancer treatment costs around Rs 75,000 to Rs 1 lakh a vial and patients generally... Read more
8d
FOX Business
PDL BioPharma, Inc. Is Off 10% in 2016, and This Is a Big Reason Whyyears was derived from its Queen et al. patents, which allowed it to reap royal
PDL BioPharma, Inc. Is Off 10% in 2016, and This Is a Big Reason Why
FOX Business / Posted 8 days ago
years was derived from its Queen et al. patents, which allowed it to reap royalties from blockbuster drugs like Avastin, Herceptin, Lucentis, and Tysabri, to name a few. However, PDL's Queen patents expired in Dec. 2014. The good news is that PDL... Read more
8d
FOX Business
PDL BioPharma, Inc. Is Off 10% in 2016, and This Is a Big Reason Whyyears was derived from its Queen et al. patents, which allowed it to reap royal
PDL BioPharma, Inc. Is Off 10% in 2016, and This Is a Big Reason Why
FOX Business / Posted 8 days ago
years was derived from its Queen et al. patents, which allowed it to reap royalties from blockbuster drugs like Avastin, Herceptin, Lucentis, and Tysabri, to name a few. However, PDL's Queen patents expired in Dec. 2014. The good news is that PDL... Read more
9d
FOX Business
1 Stock to Invest in Big PharmaBig Pharma stock, I'd go withRoche in a heartbeat. I'll start with the bad news
1 Stock to Invest in Big Pharma
FOX Business / Posted 9 days ago
Big Pharma stock, I'd go withRoche in a heartbeat. I'll start with the bad news: Its aging cancer therapies, Rituxan and Herceptin, first earned FDA approval in 1997 and 1998, respectively. Combined, these two drugs were responsible for 28% of... Read more
9d
FOX Business
1 Stock to Invest in Big PharmaBig Pharma stock, I'd go withRoche in a heartbeat. I'll start with the bad news
1 Stock to Invest in Big Pharma
FOX Business / Posted 9 days ago
Big Pharma stock, I'd go withRoche in a heartbeat. I'll start with the bad news: Its aging cancer therapies, Rituxan and Herceptin, first earned FDA approval in 1997 and 1998, respectively. Combined, these two drugs were responsible for 28% of... Read more
10d
FOX Business
2 Biotech Stocks That Could Raise Their Dividends -- and 1 That Won'tcrown jewel for quite a while has been its Queen et al. patents for a bevy of p
2 Biotech Stocks That Could Raise Their Dividends -- and 1 That Won't
FOX Business / Posted 10 days ago
crown jewel for quite a while has been its Queen et al. patents for a bevy of profitable drugs, including Avastin, Herceptin, Lucentis, Xolair, and Tysabri. But the Queen patents expired in late 2014. While the biotech managed to keep a... Read more
10d
FOX Business
2 Biotech Stocks That Could Raise Their Dividends -- and 1 That Won'tcrown jewel for quite a while has been its Queen et al. patents for a bevy of p
2 Biotech Stocks That Could Raise Their Dividends -- and 1 That Won't
FOX Business / Posted 10 days ago
crown jewel for quite a while has been its Queen et al. patents for a bevy of profitable drugs, including Avastin, Herceptin, Lucentis, Xolair, and Tysabri. But the Queen patents expired in late 2014. While the biotech managed to keep a... Read more
15d
Business Wire
Therapeutic Antibody Reports Bundle 2016: Key Report on ADCs, Bispecifics, Biosimilars & BiosuperiorsEGF-R). Relevant first wave originator therapeutic antibodies are Humira, Enbr
Therapeutic Antibody Reports Bundle 2016: Key Report on ADCs, Bispecifics, Biosimilars & Biosuperiors
Business Wire / Posted 15 days ago
EGF-R). Relevant first wave originator therapeutic antibodies are Humira, Enbrel, Remicade, Avastin, Lucentis, Eylea, Herceptin, Rituxan / MabThera and Erbitux. Second generation therapeutic antibodies against these targets such as Symponi,... Read more
19d
WFMJ Youngstown
Pittsburgh researcher infected with Zika in lab accidentHER2-positive breast cancer, a similar but less expensive experimental drug wor
Pittsburgh researcher infected with Zika in lab accident
WFMJ Youngstown / Posted 19 days ago
HER2-positive breast cancer, a similar but less expensive experimental drug works just as well as the standard drug Herceptin (trastuzumab), a new study finds. For women with advanced HER2-positive breast cancer, a similar but less... Read more
20d
KCBD-TV Lubbock
Microneedling, turning back the clock without surgeryHER2-positive breast cancer, a similar but less expensive experimental drug wor
Microneedling, turning back the clock without surgery
KCBD-TV Lubbock / Posted 20 days ago
HER2-positive breast cancer, a similar but less expensive experimental drug works just as well as the standard drug Herceptin (trastuzumab), a new study finds. For women with advanced HER2-positive breast cancer, a similar but less... Read more
21d
KFVS 12 Cape Girardeau
Cheaper breast cancer drug does well in clinical trialHER2-positive breast cancer, a similar but less expensive experimental drug wor
Cheaper breast cancer drug does well in clinical trial
KFVS 12 Cape Girardeau / Posted 21 days ago
HER2-positive breast cancer, a similar but less expensive experimental drug works just as well as the standard drug Herceptin (trastuzumab), a new study finds. HER2-positive tumors contain certain genes that are associated with more rapid... Read more
5 related stories
22d
Business Wire
Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 UpdateEGF-R). Relevant first wave originator therapeutic antibodies are Humira, Enbr
Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update
Business Wire / Posted 22 days ago
EGF-R). Relevant first wave originator therapeutic antibodies are Humira, Enbrel, Remicade, Avastin, Lucentis, Eylea, Herceptin, Rituxan / MabThera and Erbitux. Second generation therapeutic antibodies against these targets such as Symponi,... Read more
22d
Hawaii News Now
Cancer drugs less affordable in poor nations than USadjusted for differences in living standards in each country. The patented, or
Cancer drugs less affordable in poor nations than US
Hawaii News Now / Posted 22 days ago
adjusted for differences in living standards in each country. The patented, or brand-name, drugs included Avastin, Herceptin and Rituxan. Patents give a monopoly for a decade or longer. For the eight patented drugs, the median monthly... Read more
15 related stories
22d
Your Hometown Lima Stations
Cancer drugs less affordable in poor nations than USadjusted for differences in living standards in each country. The patented, or
Cancer drugs less affordable in poor nations than US
Your Hometown Lima Stations / Posted 22 days ago
adjusted for differences in living standards in each country. The patented, or brand-name, drugs included Avastin, Herceptin and Rituxan. Patents give a monopoly for a decade or longer. For the eight patented drugs, the median monthly... Read more
15 related stories
22d
Everett Herald
Study: Cancer drugs less affordable in poor nations than U.S.product, adjusted for differences in living standards in each country.The paten
Study: Cancer drugs less affordable in poor nations than U.S.
Everett Herald / Posted 22 days ago
product, adjusted for differences in living standards in each country.The patented, or brand-name, drugs included Avastin, Herceptin and Rituxan. Patents give a monopoly for a decade or longer.For the eight patented drugs, the median monthly price... Read more
15 related stories
22d
Salon.com
Cancer drugs less affordable in poor nations than USdifferences in living standards in each country. You Might Also Like The pate
Cancer drugs less affordable in poor nations than US
Salon.com / Posted 22 days ago
differences in living standards in each country. You Might Also Like The patented, or brand-name, drugs included Avastin, Herceptin and Rituxan. Patents give a monopoly for a decade or longer. For the eight patented drugs, the median monthly... Read more
15 related stories
22d
KFVS 12 Cape Girardeau
U.S. pays highest prices for cancer medsthe lung and pancreatic cancer drug Tarceva (erlotinib), which costs around $7,
U.S. pays highest prices for cancer meds
KFVS 12 Cape Girardeau / Posted 22 days ago
the lung and pancreatic cancer drug Tarceva (erlotinib), which costs around $7,700 a month; and the breast cancer drug Herceptin (trastuzumab), which costs more than $5,300 a month, the researchers said. On average, the study found that... Read more
15 related stories
22d
Newsmax
Breast Cancer Survivors Need Heart Monitoringthe 1,229 breast cancer patients who were treated with either anthracyclines al
Breast Cancer Survivors Need Heart Monitoring
Newsmax / Posted 22 days ago
the 1,229 breast cancer patients who were treated with either anthracyclines alone or combined with the monoclonal antibody Herceptin (trastuzumab) between 2003 and 2014. Both these cancer drugs increase the risk of weakening the heart. Despite... Read more
22d
Newsmax
US Pays Highest Cost for Cancer Medsthe lung and pancreatic cancer drug Tarceva (erlotinib), which costs around $7,
US Pays Highest Cost for Cancer Meds
Newsmax / Posted 22 days ago
the lung and pancreatic cancer drug Tarceva (erlotinib), which costs around $7,700 a month; and the breast cancer drug Herceptin (trastuzumab), which costs more than $5,300 a month, the researchers said. On average, the study found that... Read more
15 related stories
22d
FOX Business
Better Dividend Stock: Pfizer vs. Amgentoo, and has three (ABP 215, ABP 501, and ABP 980 -- which are biosimilars to t
Better Dividend Stock: Pfizer vs. Amgen
FOX Business / Posted 22 days ago
too, and has three (ABP 215, ABP 501, and ABP 980 -- which are biosimilars to the blockbuster drugs Avastin, Humira, and Herceptin, respectively) expecting phase 3 readouts or global regulatory action in 2016. This isn't necessarily a zero-sum... Read more
3 related stories
22d
FOX Business
Better Dividend Stock: Pfizer vs. Amgentoo, and has three (ABP 215, ABP 501, and ABP 980 -- which are biosimilars to t
Better Dividend Stock: Pfizer vs. Amgen
FOX Business / Posted 22 days ago
too, and has three (ABP 215, ABP 501, and ABP 980 -- which are biosimilars to the blockbuster drugs Avastin, Humira, and Herceptin, respectively) expecting phase 3 readouts or global regulatory action in 2016. This isn't necessarily a zero-sum... Read more
3 related stories
23d
The Financial Express
Biocon shares hit 52-week high, here is whyand safety of MYL-1401O, a proposed biosimilar trastuzumab co-developed by the
Biocon shares hit 52-week high, here is why
The Financial Express / Posted 23 days ago
and safety of MYL-1401O, a proposed biosimilar trastuzumab co-developed by the firms, in comparison to Roche’s branded Herceptin used for treatment of cancer. (Reuters) Biocon shares jumped over 4 per cent and touched its 52-week high of Rs... Read more
5 related stories
23d
The Financial Express
Thyrocare Technologies, Adani Enterprises among 11 stocks in focus in Monday’s tradeand safety of MYL-1401O, a proposed biosimilar trastuzumab co-developed by the
Thyrocare Technologies, Adani Enterprises among 11 stocks in focus in Monday’s trade
The Financial Express / Posted 23 days ago
and safety of MYL-1401O, a proposed biosimilar trastuzumab co-developed by the firms, in comparison to Roche’s branded Herceptin used for treatment of cancer. Oriental Bank of Commerce: Stocks of the bank will be in focus as it is aiming for a... Read more
3 related stories
23d
Fortune
How Mylan Is Taking On One of the World's Top Breast Cancer DrugsDrugmaker Mylan hopes to challenge one of the world’s top breast cancer treatme
How Mylan Is Taking On One of the World's Top Breast Cancer Drugs
Fortune / Posted 23 days ago
Drugmaker Mylan hopes to challenge one of the world’s top breast cancer treatments, Roche/Genentech’s Herceptin, with a copycat drug the company says will be less pricey. The firm unveiled new late-stage clinical trial data showing that its... Read more
5 related stories
24d
Decclan Chronicle
Study finds targeted cancer drugs may work in range of tumor typesof six with biliary cancer saw tumor shrinkage of 30 percent or more after trea
Study finds targeted cancer drugs may work in range of tumor types
Decclan Chronicle / Posted 24 days ago
of six with biliary cancer saw tumor shrinkage of 30 percent or more after treatment with a combination of Roche drugs Herceptin and Perjeta, which target HER2 and are typically used to treat breast cancer. The researchers said the trial will... Read more
8 related stories
24d
Business Standard India
Mylan, Biocon confirm efficacy of trastuzumab biosimilarand safety of MYL-1401O, a proposed biosimilar Trastuzumab co-developed by the
Mylan, Biocon confirm efficacy of trastuzumab biosimilar
Business Standard India / Posted 24 days ago
and safety of MYL-1401O, a proposed biosimilar Trastuzumab co-developed by the firms, in comparison to Roche’s branded Herceptin used for treatment of cancer. The companies will present data from a clinical study during the American Society of... Read more
5 related stories
24d
The Hindu
Mylan, Biocon report efficacy of cancer drugand safety of MYL-1401O, a proposed biosimilar trastuzumab co-developed by the
Mylan, Biocon report efficacy of cancer drug
The Hindu / Posted 24 days ago
and safety of MYL-1401O, a proposed biosimilar trastuzumab co-developed by the firms, in comparison to Roche’s branded Herceptin used for treatment of cancer. The companies will present data from a clinical study during the American Society of... Read more
5 related stories
24d
FOX Business
The New $17 Billion Market You've Probably Never Heard of (and 3 Stocks Poised to Profit)blockbuster treatment Humira (the highest-grossing drug in the world last year)
The New $17 Billion Market You've Probably Never Heard of (and 3 Stocks Poised to Profit)
FOX Business / Posted 24 days ago
blockbuster treatment Humira (the highest-grossing drug in the world last year) and cancer treatments Avastin, Rituxan, and Herceptin.Changing lanes Biogen is mostly known for its massive multiple-sclerosis drug franchise, which includes... Read more
3 related stories
24d
FOX Business
The New $17 Billion Market You've Probably Never Heard of (and 3 Stocks Poised to Profit)blockbuster treatment Humira (the highest-grossing drug in the world last year)
The New $17 Billion Market You've Probably Never Heard of (and 3 Stocks Poised to Profit)
FOX Business / Posted 24 days ago
blockbuster treatment Humira (the highest-grossing drug in the world last year) and cancer treatments Avastin, Rituxan, and Herceptin.Changing lanes Biogen is mostly known for its massive multiple-sclerosis drug franchise, which includes... Read more
3 related stories
24d
Fortune
Study Finds Targeted Cancer Drugs May Work in Range of Tumor Typesand three of six with biliary cancer saw tumor shrinkage of 30% or more after t
Study Finds Targeted Cancer Drugs May Work in Range of Tumor Types
Fortune / Posted 24 days ago
and three of six with biliary cancer saw tumor shrinkage of 30% or more after treatment with a combination of Roche drugs Herceptin and Perjeta, which target HER2 and are typically used to treat breast cancer. The researchers said the trial will... Read more
8 related stories
24d
Raw Story
Study finds targeted cancer drugs may be effective in a range of tumor typesof six with biliary cancer saw tumor shrinkage of 30 percent or more after trea
Study finds targeted cancer drugs may be effective in a range of tumor types
Raw Story / Posted 24 days ago
of six with biliary cancer saw tumor shrinkage of 30 percent or more after treatment with a combination of Roche drugs Herceptin and Perjeta, which target HER2 and are typically used to treat breast cancer. The researchers said the trial will... Read more
8 related stories
25d
Channel NewsAsia
Study finds targeted cancer drugs may work in range of tumor typesof six with biliary cancer saw tumor shrinkage of 30 percent or more after trea
Study finds targeted cancer drugs may work in range of tumor types
Channel NewsAsia / Posted 25 days ago
of six with biliary cancer saw tumor shrinkage of 30 percent or more after treatment with a combination of Roche drugs Herceptin and Perjeta, which target HER2 and are typically used to treat breast cancer. The researchers said the trial will... Read more
8 related stories
25d
Daily Mail
Scientists identify 'Achilles heel' of conditionhigh levels are found in about one in five breast and stomach cancers, known as
Scientists identify 'Achilles heel' of condition
Daily Mail / Posted 25 days ago
high levels are found in about one in five breast and stomach cancers, known as HER2-positive types. The cancer drugs Herceptin and Perjeta – the brand names for trastuzumab and pertuzumab, respectively – recognise HER2 but they do not kill... Read more
5 related stories
25d
Channel NewsAsia
Copycat biotech cancer drug works as well as Roche originalREUTERS: A copycat version of Roche Holding AG's breast cancer drug Herceptin w
Copycat biotech cancer drug works as well as Roche original
Channel NewsAsia / Posted 25 days ago
REUTERS: A copycat version of Roche Holding AG's breast cancer drug Herceptin worked as well, and as safely, as the original biotechnology treatment in the first-ever study to compare such a "biosimilar" to a brand-name drug. Results from the... Read more
5 related stories
25d
The Economic Times
Now, Reliance Life Sciences appeals marketing restrictions on its breast cancer drugTrastuRel without calling it a "bio similar" or in any way ascribing biosimilar
Now, Reliance Life Sciences appeals marketing restrictions on its breast cancer drug
The Economic Times / Posted 25 days ago
TrastuRel without calling it a "bio similar" or in any way ascribing biosimilarity to the inventor, Roche's products—Herceptin , Herclon and Biceltis. The company's appeal will be heard along with Biocon and Mylan's by Justices Badar Durrez... Read more
26d
Daily Mail
Have we cracked breast cancer? 'Achilles heel' of the disease foundlevels are found in about one in five breast and stomach cancer and known as HE
Have we cracked breast cancer? 'Achilles heel' of the disease found
Daily Mail / Posted 26 days ago
levels are found in about one in five breast and stomach cancer and known as HER2 positive cancers. Cancer drugs Herceptin, the brand name for trastuzumab and Perjeta, the brand pertuzumab, recognise the receptor but they do not kill off... Read more
5 related stories
26d
Daily Mirror
The 'Achilles heel' of breast cancer cells has been identified, scientists claimlevels are found in about one in five breast and stomach cancers and are known
The 'Achilles heel' of breast cancer cells has been identified, scientists claim
Daily Mirror / Posted 26 days ago
levels are found in about one in five breast and stomach cancers and are known as HER2 positive cancers. Cancer drugs Herceptin - the brand name for trastuzumab - and Perjeta - also known as pertuzumab - recognise the receptor but they do not... Read more
5 related stories
27d
FOX Business
Why Galena Biopharma, Inc. Was on the Fast Track to a Higher Stock Price Todayintermediate expression of a protein called HER2. Tumors with high expression o
Why Galena Biopharma, Inc. Was on the Fast Track to a Higher Stock Price Today
FOX Business / Posted 27 days ago
intermediate expression of a protein called HER2. Tumors with high expression of HER2 are treated with drugs like Roche's Herceptin or Kadcyla, but those with low to intermediate HER2 expressions have fewer options to prevent recurrence. The... Read more
27d
FOX Business
Why Galena Biopharma, Inc. Was on the Fast Track to a Higher Stock Price Todayintermediate expression of a protein called HER2. Tumors with high expression o
Why Galena Biopharma, Inc. Was on the Fast Track to a Higher Stock Price Today
FOX Business / Posted 27 days ago
intermediate expression of a protein called HER2. Tumors with high expression of HER2 are treated with drugs like Roche's Herceptin or Kadcyla, but those with low to intermediate HER2 expressions have fewer options to prevent recurrence. The... Read more
29d
FOX Business
These 5 Big Pharma Stocks Are Ridiculously Cheapbig pharma stock boasts a hefty 3.6% dividend yield.Roche is firing on all cyli
These 5 Big Pharma Stocks Are Ridiculously Cheap
FOX Business / Posted 29 days ago
big pharma stock boasts a hefty 3.6% dividend yield.Roche is firing on all cylinders Roche's top selling drugs Rituxan and Herceptin are widely expected to face pricing pressure from biosimilar competition in the years ahead. In the first quarter... Read more
29d
FOX Business
These 5 Big Pharma Stocks Are Ridiculously Cheapbig pharma stock boasts a hefty 3.6% dividend yield.Roche is firing on all cyli
These 5 Big Pharma Stocks Are Ridiculously Cheap
FOX Business / Posted 29 days ago
big pharma stock boasts a hefty 3.6% dividend yield.Roche is firing on all cylinders Roche's top selling drugs Rituxan and Herceptin are widely expected to face pricing pressure from biosimilar competition in the years ahead. In the first quarter... Read more
m
FOX Business
Regeneron Pharmaceuticals, Inc. vs. Rochefrom biosimilars -- generic forms of complex biologic drugs -- in the near futu
Regeneron Pharmaceuticals, Inc. vs. Roche
FOX Business / Posted 1 months ago
from biosimilars -- generic forms of complex biologic drugs -- in the near future. Sales of cancer therapies Rituxan and Herceptin are still growing by single digits despite first earning FDA approval in 1997 and 1998, respectively. In the first... Read more
m
FOX Business
Regeneron Pharmaceuticals, Inc. vs. Rochefrom biosimilars -- generic forms of complex biologic drugs -- in the near futu
Regeneron Pharmaceuticals, Inc. vs. Roche
FOX Business / Posted 1 months ago
from biosimilars -- generic forms of complex biologic drugs -- in the near future. Sales of cancer therapies Rituxan and Herceptin are still growing by single digits despite first earning FDA approval in 1997 and 1998, respectively. In the first... Read more
m
The Economic Times
Biotech giant Roche takes NPPA to court over cap on injection priceceiling price it fixed for breast cancer injection trastuzumab. The Swiss compa
Biotech giant Roche takes NPPA to court over cap on injection price
The Economic Times / Posted 1 months ago
ceiling price it fixed for breast cancer injection trastuzumab. The Swiss company sells the injection under the brand name Herceptin internationally and Herclon in India. On May 9, the NPPA issued a notification capping the price of trastuzumab... Read more
m
Scoop.co.nz
Dunne Speaks: Meanwhile, after the Budget ...and may not be able to be funded within PHARMAC’s existing budget and criteria.
Dunne Speaks: Meanwhile, after the Budget ...
Scoop.co.nz / Posted 1 months ago
and may not be able to be funded within PHARMAC’s existing budget and criteria. The debate over the breast cancer drug Herceptin in 2007-09 was one such example. The upshot was that the government made specific funding available for Herceptin... Read more
m
News-Medical-Net
First large-scale proteogenomic study helps pinpoint genes that drive breast cancerand physicians hope to identify more druggable kinase proteins in addition to H
First large-scale proteogenomic study helps pinpoint genes that drive breast cancer
News-Medical-Net / Posted 1 months ago
and physicians hope to identify more druggable kinase proteins in addition to HER2, which can be targeted with trastuzumab (Herceptin) but only in 20 percent of breast cancers that overexpress the HER2 protein. In this study, the researchers... Read more

People in this news